Actinium Pharmaceuticals, Inc. (NYSE: ATNM) ("Actinium") today announced the pricing of an underwritten public offering of 42,860,000 shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE